%0 Journal Article
%K Humans
%K United Kingdom/epidemiology
%K Female
%K Middle Aged
%K Aged
%K Male
%K Incidence
%K Adult
%K *Breast Neoplasms/epidemiology/mortality
%K Prevalence
%K Aged, 80 and over
%K Adolescent
%K Young Adult
%K Breast Neoplasms, Male/epidemiology/mortality
%K Survival Rate
%B Sci Rep
%D 2024
%G eng
%M 39153995
%P 19069
%R 10.1038/s41598-024-69006-1
%T Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021
%V 14
%2 PMC11330450 from the European Medicines Agency from the Innovative Medicines Initiative from Amgen Chiesi and from UCB Biopharma; and consultancy or speaker fees (paid to his department) from Astellas Amgen Astra Zeneca and UCB Biopharma. NLB is Director of Sleep Universal Limited (though this work is in no way connected to the present manuscript). All other authors declare no conflicts of interest.
%7 2024/08/18
%@ 2045-2322